Cargando…

Associations between body mass index and the risk of renal events in patients with type 2 diabetes

BACKGROUND/OBJECTIVES: We aimed to evaluate the relationship between BMI and the risk of renal disease in patients with type 2 diabetes in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study. SUBJECTS/METHODS: Participants were d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammedi, Kamel, Chalmers, John, Herrington, William, Li, Qiang, Mancia, Giuseppe, Marre, Michel, Poulter, Neil, Rodgers, Anthony, Williams, Bryan, Perkovic, Vlado, Coresh, Josef, Woodward, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851426/ https://www.ncbi.nlm.nih.gov/pubmed/29343817 http://dx.doi.org/10.1038/s41387-017-0012-y

Ejemplares similares

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hillis, Graham S., et al.
Publicado: (2012)

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
por: Oshima, Megumi, et al.
Publicado: (2019)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
por: van Steen, Sigrid C., et al.
Publicado: (2018)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
por: Herrington, William G., et al.
Publicado: (2017)

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2022)

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial
por: Thomas, Merlin C., et al.
Publicado: (2018)

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
por: Blomster, Juuso I, et al.
Publicado: (2016)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, Paul, et al.
Publicado: (2018)

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis
por: Lv, Jicheng, et al.
Publicado: (2012)

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference
por: Baigent, Colin, et al.
Publicado: (2017)

Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program
por: Ohkuma, Toshiaki, et al.
Publicado: (2020)

Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2014)

New hypoglycemic agents and the kidney: what do the major trials tell us?
por: Smyth, Brendan, et al.
Publicado: (2018)

Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Arnott, Clare, et al.
Publicado: (2020)

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus
por: Potier, Louis, et al.
Publicado: (2018)

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
por: Nativel, Mathilde, et al.
Publicado: (2018)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
por: Hua, X., et al.
Publicado: (2020)

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
por: Tremblay, Johanne, et al.
Publicado: (2021)

Blood pressure: at what level is treatment worthwhile?
por: Atkins, Emily R, et al.
Publicado: (2019)

Effectiveness of two‐drug therapy versus monotherapy as initial regimen in hypertension: A propensity score‐matched cohort study in the UK Clinical Practice Research Datalink
por: Marinier, Karine, et al.
Publicado: (2019)

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review
por: Smyth, Brendan, et al.
Publicado: (2019)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
por: Jun, Min, et al.
Publicado: (2019)

Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2015)

Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial
por: Hata, Jun, et al.
Publicado: (2013)

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
por: Neuen, Brendon L, et al.
Publicado: (2020)

Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes
por: Sanchez, Manuel, et al.
Publicado: (2022)

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
por: Mahaffey, Kenneth W., et al.
Publicado: (2018)

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis
por: Jardine, Meg J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ollkt6gjgct0nehj0fshsbucrb